Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
| Novartis Pharmaceuticals Corporation |
| Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc., Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc., Natco Pharma, Inc. and Natco Pharma Limited |
| 1:2019cv02021 |
| October 24, 2019 |
| U.S. District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 12, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Natco Pharma Limited waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel) |
| Filing 10 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Natco Pharma, Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel) |
| Filing 9 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Macleods Pharmaceuticals Ltd. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel) |
| Filing 8 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Macleods Pharma USA, Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel) |
| Filing 7 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Alembic Pharmaceuticals Limited waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel) |
| Filing 6 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Alembic Pharmaceuticals, Inc. waiver sent on 11/8/2019, answer due 1/7/2020. (Silver, Daniel) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (kmd) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,101,659; 8,796,331; 8,877,938; 9,388,134. (kmd) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/11/2019. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 7/7/2023. (kmd) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Filing 1 COMPLAINT filed against Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Natco Pharma Limited, Natco Pharma, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2763203.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibits A-D, #2 Civil Cover Sheet)(kmd) |
| No Summons Issued. (kmd) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
